BRIDGEBIO PHARMA INC - NOTE 2.250% 2/0

Historical Holders from Q1 2022 to Q3 2025

Type / Class
Debt / NOTE 2.250% 2/0
All holders as of 30 Sep 2025
Q3 2025
Total 13F principal, excl. options
627,523,074
Holdings value
$621,164,871
% of all portfolios
0%
Number of holders
42
Number of buys
15
Number of sells
-20
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of BRIDGEBIO PHARMA INC - NOTE 2.250% 2/0

Period Principal Value Change Price Investors
2025 Q3 627,523,074 $621,164,871 -$32,020,133 $0.9882 42
2025 Q2 677,587,704 $702,102,373 -$9,786,616 $0.9358 40
2025 Q1 692,365,423 $625,022,166 +$61,676,686 $0.9 41
2024 Q4 627,730,524 $538,661,074 -$2,449,849 $0.8563 38
2024 Q3 632,466,339 $531,505,798 -$6,333,280 $0.8361 38
2024 Q2 641,592,339 $515,193,030 -$52,483,886 $0.8012 42
2024 Q1 705,552,289 $610,874,985 -$20,650,206,952 $0.8193 44
2023 Q4 738,008,709 $628,227,229 +$26,540,307 $0.8469 41
2023 Q3 709,803,792 $535,567,910 +$79,827,117 $0.75 45
2023 Q2 610,911,952 $378,751,579 -$2,520,238 $0.6177 41
2023 Q1 623,666,127 $401,644,918 +$18,976,107 $0.6393 44
2022 Q4 622,846,458 $239,898,646 -$41,611,016 $0.3823 35
2022 Q3 580,552,458 $262,269,316 +$1,575,782 $0.4415 33
2022 Q2 594,504,458 $253,628,177 -$25,432,130 $0.4087 34
2022 Q1 625,412,958 $310,645,005 +$309,619,000 $0.4762 36